Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
2seventy Bio
2seventy Bio
(TSVT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lornoxicam
burkitt lymphoma
,
precursor b-cell lymphoblastic leukemia-lymphoma
,
leukemia
,
t-cell lymphoma peripheral
,
lymphoid leukemia
,
osteosarcoma
,
neoplasm metastasis
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
ovarian neoplasms
,
triple negative breast neoplasms
,
glioblastoma
,
glioma
,
astrocytoma
,
neoplasms
,
b-cell lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
neuroblastoma
,
diffuse intrinsic pontine glioma
,
sarcoma
,
medulloblastoma
,
rhabdoid tumor
,
ewing sarcoma
,
rhabdomyosarcoma
,
waldenstrom macroglobulinemia
,
large b-cell lymphoma diffuse
,
recurrence
,
systemic scleroderma
,
skin diseases
,
diffuse scleroderma
,
hodgkin disease
,
breast neoplasms
,
lymphoma
,
non-hodgkin lymphoma
,
adenocarcinoma
,
mantle-cell lymphoma
,
follicular lymphoma
,
myeloid leukemia acute
,
residual neoplasm
,
rheumatoid arthritis
,
obesity
,
arthritis
Cc5013
plasma cell neoplasms
,
neoplasms
,
hematologic diseases
,
blood protein disorders
,
paraproteinemias
,
corneal diseases
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
lymphoma
,
multiple myeloma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use